The clinically proven3 Pipeline™ Flex embolization device redefines treatment for certain wide-necked intracranial aneurysms by diverting flow away from the aneurysm neck, reconstructing the parent artery and restoring its natural course.4,5Product Details
Shield Technology™ builds on the clinically proven treatment of certain wide-necked intracranial aneurysms with the PIpeline™ Flex embolization device, by introducing an innovative implant surface modification, designed to advance flow diversion therapy3,6Product Details
Data on file. TR-NV14378A.
Data on file. TR-NV12442A. Based on bench test comparing average work number of Axium™ Prime extra soft coil versus Target® Nano™ coil. 20 units of each coil were tested. Bench testing is not indicative of clinical performance.; Determined using formula for cylinder (volume = πr2 x length). Based on calculated k-factor values.; TR-NV12051A; TR-NV12197B; TR-NV10304A; TR-NV13164C; TR09-218A.
Medtronic Internal Report FD3456B, PUFS 5 Year CSR.
Becske T. et al., Pipeline for Uncoilable or Failed Aneurysms. Results from a Multicenter Clinical Trial. Radiology. Published online Feb 15, 2013.
Kallmes, DF et al. International Retrospective Study of the Pipeline Embolization Device: A Multicenter Aneurysm Treatment Study, AJNR Published online, Oct 29, 2014.
Girdhar G, Li J, Kostousov L, Wainwright J, Chandler WL. In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices. J Thromb Thrombolysis. 2015 Nov;40(4):437-43. doi: 10.1007/s11239-015-1228-0. PMID: 25975924.